1. Trigg ME, Polpack DG: Transplantation of leukaemic bone marrow incubated with cytotoxic antibodies. In: W. Knapp (ed) Leukaemia Markers, pp. 425–428, Academic Press, London (1981).
2. Bast RC Jr, Ritz J, Lipton, JM, Feeney M, Lipton J, Sallan SE, Nathan DG, Schlossman SF: Elimination of leukaemic cells from human bone marrow using monoclonal antibodies and complement. Cancer Res. 43:1389 (1983)
3. Carson DA, Kaye J, Seegmiller JE: Differential sensitivity of human leukaemic T cell lines and B cell lines to growth inhibition by deoxyadenosine. J Immunol 121:1726 (1978).
4. Smyth JF, Paine RM, Jackman AL, Harrap KR, Chassin MM, Adamson RH, Johns DG: The clinical pharmacology of the adenosine deaminase inhibitor 2′deoxycoformycin. Cancer Chemother Pharmacol 5:93 (1980).
5. Prentice HG, Smyth JF, Ganeshaguru K, Wonke B, Bradstock KF, Janossy G, Goldstone AH, Hoffbrand AV: Remission induction with the adenosine deaminase inhibitor 2′deoxycoformycin in Thy-acute lymphoblastic leukaemia. Lancet ii:170 (1980).